[go: up one dir, main page]

GB201603886D0 - Compounds for the treatment of type 2 diabetes - Google Patents

Compounds for the treatment of type 2 diabetes

Info

Publication number
GB201603886D0
GB201603886D0 GBGB1603886.1A GB201603886A GB201603886D0 GB 201603886 D0 GB201603886 D0 GB 201603886D0 GB 201603886 A GB201603886 A GB 201603886A GB 201603886 D0 GB201603886 D0 GB 201603886D0
Authority
GB
United Kingdom
Prior art keywords
diabetes
compounds
treatment
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1603886.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atrogi AB
Original Assignee
Atrogi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atrogi AB filed Critical Atrogi AB
Priority to GBGB1603886.1A priority Critical patent/GB201603886D0/en
Publication of GB201603886D0 publication Critical patent/GB201603886D0/en
Priority to EP17715967.0A priority patent/EP3426239A1/en
Priority to US16/082,750 priority patent/US20190119196A1/en
Priority to JP2018566649A priority patent/JP7046842B2/en
Priority to PCT/GB2017/050605 priority patent/WO2017153737A1/en
Priority to KR1020187028730A priority patent/KR20180117696A/en
Ceased legal-status Critical Current

Links

GBGB1603886.1A 2016-03-07 2016-03-07 Compounds for the treatment of type 2 diabetes Ceased GB201603886D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1603886.1A GB201603886D0 (en) 2016-03-07 2016-03-07 Compounds for the treatment of type 2 diabetes
EP17715967.0A EP3426239A1 (en) 2016-03-07 2017-03-07 Compounds for the treatment of hyperglycaemia
US16/082,750 US20190119196A1 (en) 2016-03-07 2017-03-07 Compounds for the treatment of hyperglycaemia
JP2018566649A JP7046842B2 (en) 2016-03-07 2017-03-07 Compounds for the treatment of hyperglycemia
PCT/GB2017/050605 WO2017153737A1 (en) 2016-03-07 2017-03-07 Compounds for the treatment of hyperglycaemia
KR1020187028730A KR20180117696A (en) 2016-03-07 2017-03-07 Compound for the treatment of hyperglycemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1603886.1A GB201603886D0 (en) 2016-03-07 2016-03-07 Compounds for the treatment of type 2 diabetes

Publications (1)

Publication Number Publication Date
GB201603886D0 true GB201603886D0 (en) 2016-04-20

Family

ID=55859096

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1603886.1A Ceased GB201603886D0 (en) 2016-03-07 2016-03-07 Compounds for the treatment of type 2 diabetes

Country Status (1)

Country Link
GB (1) GB201603886D0 (en)

Similar Documents

Publication Publication Date Title
IL275482A (en) Esketamine for the treatment of depression
IL264049A (en) Compounds, compositions, and methods for the treatment of disease
IL258471A (en) 11,13-modified saxitoxins for the treatment of pain
IL264156A (en) Compounds, compositions, and methods for the treatment of disease
SMT201900172T1 (en) 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
SI3416957T1 (en) 6-heterocyclyl-4-morpholin-4-ylpyridin-2-one compounds useful for the treatment of cancer and diabetes
GB201612165D0 (en) Combinations for the treatment of type 2 diabetes
HUE051654T2 (en) Composition for the treatment of acne
PT3416945T (en) 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes
ZA202002993B (en) Compounds for the treatment of neuromuscular disorders
IL259297A (en) Heterocyclic compounds for the treatment of disease
GB201707207D0 (en) Treatment of type 1 diabetes
PL3484475T3 (en) 1-methylnicotinamide for the treatment of cardiovascular disease
IL252899A0 (en) Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes
ZA201804588B (en) Pharmaceutical formulations for the treatment of diabetes
PL3630754T3 (en) Isoindoline-acetylene compounds for the treatment of cancer
SMT201800378T1 (en) 3,4-diamino-6-chloropyrazine-2-carboxamide compounds for the treatment of enac mediated diseases
HK40070316B (en) Heterocyclic compounds for the treatment of disease
GB201603886D0 (en) Compounds for the treatment of type 2 diabetes
GB201603882D0 (en) Compounds for the treatment of type 2 diabetes
PT3724173T (en) Compounds for the treatment of neuromuscular disorders
GB201701928D0 (en) Compounds for the treatment of hyperglycaemia
PT3524255T (en) Composition for the treatment of acne

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)